Profund Advisors LLC Ionis Pharmaceuticals Inc Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Profund Advisors LLC holds 37,596 shares of IONS stock, worth $1.28 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

37,596

Previous 29,983 25.39%

Holding current value

$1.28 Million

Previous $1.43 Million 5.46%

% of portfolio

0.06%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $304,976 - $394,810	7,613 Added 25.39%	37,596 $1.51 Million
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $57,846 - $75,699	-1,587 Reduced 5.03%	29,983 $1.43 Million
Q1 2024 May 08, 2024	BUY	$42.03 - $53.55 $104,948 - $133,714	2,497 Added 8.59%	31,570 $1.37 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $277,565 - $330,277	-6,397 Reduced 18.03%	29,073 $1.47 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $31,339 - $38,363	-814 Reduced 2.24%	35,470 $1.61 Million
Q2 2023 Aug 10, 2023	SELL	$34.73 - $43.33 $4,341 - $5,416	-125 Reduced 0.34%	36,284 $1.49 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $690,539 - $847,236	20,564 Added 129.78%	36,409 $1.3 Million
Q4 2022 Feb 02, 2023	BUY	$37.12 - $46.52 $13,660 - $17,119	368 Added 2.38%	15,845 $598,000
Q3 2022 Nov 04, 2022	SELL	$36.54 - $48.66 $26,528 - $35,327	-726 Reduced 4.48%	15,477 $685,000
Q2 2022 Aug 01, 2022	SELL	$31.71 - $43.0 $44,045 - $59,727	-1,389 Reduced 7.9%	16,203 $600,000
Q1 2022 May 10, 2022	SELL	$29.88 - $37.04 $54,531 - $67,598	-1,825 Reduced 9.4%	17,592 $652,000
Q4 2021 Feb 08, 2022	SELL	$25.61 - $35.1 $88,969 - $121,937	-3,474 Reduced 15.18%	19,417 $591,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $39,141 - $47,321	-1,167 Reduced 4.85%	22,891 $768,000
Q2 2021 Aug 12, 2021	SELL	$34.54 - $47.25 $25,525 - $34,917	-739 Reduced 2.98%	24,058 $959,000
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $156,946 - $235,475	-3,692 Reduced 12.96%	24,797 $1.12 Million
Q4 2020 Feb 09, 2021	BUY	$45.3 - $60.27 $114,156 - $151,880	2,520 Added 9.7%	28,489 $1.61 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $100,926 - $133,894	-2,127 Reduced 7.57%	25,969 $1.23 Million
Q2 2020 Aug 03, 2020	BUY	$46.85 - $61.05 $189,508 - $246,947	4,045 Added 16.82%	28,096 $1.66 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $364,956 - $556,208	-8,773 Reduced 26.73%	24,051 $1.14 Million
Q4 2019 Feb 18, 2020	BUY	$53.85 - $65.27 $183,036 - $221,852	3,399 Added 11.55%	32,824 $1.98 Million
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $303,686 - $370,995	-5,142 Reduced 14.88%	29,425 $1.76 Million
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $233,582 - $324,058	-3,762 Reduced 9.82%	34,567 $2.22 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $28,788 - $44,156	544 Added 1.44%	38,329 $3.11 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $396,271 - $544,016	-9,137 Reduced 19.47%	37,785 $2.04 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $340,209 - $426,055	7,934 Added 20.35%	46,922 $2.42 Million
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $96,015 - $120,108	-2,369 Reduced 5.73%	38,988 $1.63 Million
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $193,952 - $242,220	-4,400 Reduced 9.62%	41,357 $1.82 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $287,866 - $368,503	-5,723 Reduced 11.12%	45,757 $2.3 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $191,625 - $250,551	4,206 Added 8.9%	51,480 $2.61 Million
Q2 2017 Aug 11, 2017	BUY	N/A	47,274	47,274 $2.41 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Ionis Pharmaceuticals Inc Transaction History